Skip to content

Ultrasound as a method of aid in the treatment of patients with musculoskeletal pain

Ultrasound as an auxiliary tool in the diagnosis and treatment of patients with Myofascial Pain Syndrome. A randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-42pvd9
Enrollment
Unknown
Registered
2017-11-14
Start date
2016-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndromes

Interventions

After the initial pre-procedure evaluation, participants will be referred to the TACP lockout room. At this point, the interventional researcher will randomize the patients, in groups 1 and 2 (Figure
as well as the collaborative researcher will be blind during randomization and interventional procedures. The total volume of the anesthetic used should not
Procedure/surgery
E03.155.086.231
C10.597.617.576
N02.278.035.380.600

Sponsors

Departamento de Anestesiologia da Faculdade de Medicina de Botucatu
Lead Sponsor
Marcos André Nogueira Frasson Filho
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult participants 18 years of age or older who voluntarily signed the ICC and who have at least one active or latent Trigger Point located in the cervical, lumbar or shoulder region (trapezius, scapula lift , supraspinatus, infraspinatus), with symptoms for at least 3 months and receiving treatment, without alteration in the dosing schedule, for at least 1 month. These patients may not have undergone other invasive procedures for pain control, such as infiltration with local anesthetics of PGs, in the last 30 days.

Exclusion criteria

Exclusion criteria: Patients with the following clinical conditions will be excluded from the study: active skin lesions, uncontrolled diabetes mellitus, neurodegenerative diseases, fibromyalgia, uncontrolled arterial hypertension, known allergy to the local anesthetic presence of active bacterial infection, use of anticoagulation with altered coagulogram, patient request to leave the study and those who have low cognitive level and who do not understand the evaluation scales used. There will be no limitation between genres.

Design outcomes

Primary

MeasureTime frame
Primary outcome expected: intensity of pain, through the Verbal Numerical Scale (VNS) will be the instrument used to measure the intensity of pain at rest and movement. This method of evaluating pain in asking the patient the numerical value between 0 (absence of pain) and 10 (maximum pain possible), corresponding to the pain reported by the patient at the time of the examination. She will be applied prior to the completion of the procedure and immediately after the end of the procedure (Polly, 2003). Associated with ENV, will be used algometer (Pressoalgimeter, Top Cat Metrology, England, 2015), for the determination of pressure pain threshold before and after the procedure, in an attempt to improve the quantification of painful information objective (Annex IV).

Secondary

MeasureTime frame
Expected secondary outcome :In addition to the intensity of pain, the analgesia time between the groups, the functional evaluation scores with specific scales, according to the location of PGs, for the scapular girdle region, Neck Disability Index (Cook, 2016) (APPENDIX II) and region Owestry 2.0 Disability Index (Vigatto, 2017) (ANNEX III), which will be applied before the patient underwent the procedure, and after both interventions. Beyond In addition, the occurrence of a limitation for the exercise of work will be evaluated (ANNEX IV). If the patient presents cervical and lumbar involvement, statistical calculation, the score corresponds to the area of the highest score. Also will be evaluated the time demanded for the execution of both techniques, to evaluate the functionality of the method in the TACP outpatient clinic (ANNEX IV).

Countries

Brazil

Contacts

Public ContactMarcos André Frasson FIlho

Faculdade de Medicina de Botucatu

frasson.andre@gmail.com+55 61 999488719

Outcome results

None listed

Source: REBEC (via WHO ICTRP)